Skip to main content
Fig. 1 | BMC Pediatrics

Fig. 1

From: Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan

Fig. 1

TTIA and TTRF after treatment with baloxavir. Kaplan-Meier analysis of (a) time to illness alleviation and (b) time to resolution of fever, after treatment with baloxavir. Influenza illness was composed of cough, nasal discharge/nasal congestion, and elevated body temperature. Patients who did not experience alleviation of influenza illness or resolution of fever by the last observation time point were censored at the last observation time point. CI: confidence interval; TTIA: time to illness alleviation; TTRF: time to resolution of fever

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us